Loading...
ConvaTec Group Plc
CNVVF•PNK
Healthcare
Medical - Instruments & Supplies
$3.48
$0.00(0.00%)
ConvaTec Group Plc (CNVVF) Financial Performance & Income Statement Overview
Explore the financials of ConvaTec Group Plc (CNVVF), including yearly and quarterly data on income, cash flow, and balance sheets.
Revenue Growth
6.85%
↑ 6.85%
Operating Income Growth
23.68%
↑ 23.68%
Net Income Growth
46.20%
↑ 46.20%
Operating Cash Flow Growth
7.84%
↑ 7.84%
Operating Margin
14.59%
↑ 14.59%
Gross Margin
55.16%
↑ 55.16%
Net Profit Margin
7.83%
↑ 7.83%
ROE
15.72%
↑ 15.72%
ROIC
16.32%
↑ 16.32%
ConvaTec Group Plc (CNVVF) Income Statement & Financial Overview
Explore comprehensive income reports for ConvaTec Group Plc CNVVF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.18B | $1.11B | $1.10B | $543.45M |
| Cost of Revenue | $516.40M | $489.20M | $503.41M | $239.40M |
| Gross Profit | $659.40M | $624.20M | $600.84M | $304.05M |
| Gross Profit Ratio | $0.56 | $0.56 | $0.54 | $0.56 |
| R&D Expenses | $57.70M | $54.00M | $57.30M | $28.40M |
| SG&A Expenses | $422.60M | $417.60M | $385.66M | $201.70M |
| Operating Expenses | $483.70M | $475.00M | $442.96M | $241.25M |
| Total Costs & Expenses | $1.000B | $964.20M | $946.36M | $480.65M |
| Interest Income | $4.80M | $0.00 | $3.05M | $17.10M |
| Interest Expense | $73.50M | $0.00 | $33.53M | $0.00 |
| Depreciation & Amortization | $122.50M | $98.30M | $110.43M | $45.05M |
| EBITDA | $289.30M | $250.90M | $236.82M | $117.75M |
| EBITDA Ratio | $0.25 | $0.23 | $0.24 | $0.22 |
| Operating Income | $175.70M | $149.20M | $157.88M | $72.70M |
| Operating Income Ratio | $0.15 | $0.13 | $0.14 | $0.13 |
| Other Income/Expenses (Net) | -$33.80M | -$45.20M | -$65.02M | -$27.00M |
| Income Before Tax | $141.90M | $104.00M | $92.86M | $45.70M |
| Income Before Tax Ratio | $0.12 | $0.09 | $0.08 | $0.08 |
| Income Tax Expense | $30.60M | $25.40M | $17.07M | $8.40M |
| Net Income | $111.90M | $78.60M | $75.79M | $37.30M |
| Net Income Ratio | $0.10 | $0.07 | $0.07 | $0.07 |
| EPS | $0.05 | $0.04 | $0.04 | $0.02 |
| Diluted EPS | $0.05 | $0.04 | $0.04 | $0.02 |
| Weighted Avg Shares Outstanding | $2.05B | $2.06B | $2.04B | $2.07B |
| Weighted Avg Shares Outstanding (Diluted) | $2.06B | $2.06B | $2.05B | $2.06B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan